Provided by Tiger Trade Technology Pte. Ltd.

ALPHAMAB-B

7.995
-0.335-4.02%
Volume:103.00K
Turnover:828.05K
Market Cap:7.73B
PE:-57.03
High:8.125
Open:8.115
Low:7.995
Close:8.330
52wk High:15.750
52wk Low:6.230
Shares:967.00M
HK Float Shares:967.00M
Volume Ratio:0.83
T/O Rate:0.01%
Dividend:- -
Dividend Rate:- -
EPS(LYR):-0.140
ROE:-9.98%
ROA:-5.47%
PB:3.95
PE(LYR):-57.03
PS:12.77

Loading ...

Alphamab Oncology FY2025 operating loss widens to RMB114 million; revenue falls 11.54% to RMB566 million

Reuters
·
Mar 25

Alphamab Oncology FY2025 revenue falls to CNY 566 million; annual loss widens to CNY 114 million

Reuters
·
Mar 25

Alphamab Oncology FY Revenue RMB 566.2 Million

THOMSON REUTERS
·
Mar 25

HK Pharma Stocks Gained. Wuxi XDC Up 8%; Wuxi AppTec Up 7%; Transthera And HBM Up 5%; Keymed Bio And Innocare Up 4%; Wuxi Bio And Remegen Up 3%

Tiger Newspress
·
Mar 24

ALPHAMAB-B, CSPC Subsidiary Initiate Phase III Trial of KN026 for Adjuvant HER2-Positive Breast Cancer

Bulletin Express
·
Mar 24

ALPHAMAB-B (09966) Doses First Patient in Phase III Trial for KN026 as Adjuvant Therapy in HER2+ Breast Cancer

Stock News
·
Mar 24

Alphamab Oncology doses first patient in Phase 3 KN026 adjuvant HER2+ breast cancer trial

Reuters
·
Mar 24

Alphamab Oncology Doses First Patient in JSKN016 Study

MT Newswires Live
·
Mar 20

ALPHAMAB Oncology (09966.HK) Initiates Phase III Trial: First Patient Dosed with Bispecific ADC JSKN016 for Triple-Negative Breast Cancer

Bulletin Express
·
Mar 20

Alphamab Oncology doses first patient in Phase III JSKN016-301 trial for triple-negative breast cancer

Reuters
·
Mar 20

BRIEF-Alphamab Oncology Appoints Wang Fei As CFO

Reuters
·
Mar 18

Alphamab Oncology Names Former 3SBio Executive as CFO

MT Newswires Live
·
Mar 18

Alphamab-B (09966) Announces Appointment of Wang Fei as Chief Financial Officer; Capital-Markets Vice President Chai Bo to Step Down

Bulletin Express
·
Mar 18

ALPHAMAB-B Appoints Wang Fei as Chief Financial Officer

Stock News
·
Mar 18

Alphamab Oncology - Appoints Wang Fei as CFO

THOMSON REUTERS
·
Mar 18

Alphamab Oncology appoints Wang Fei as CFO effective March 16, 2026

Reuters
·
Mar 18

Alphamab Oncology Doses First Patient in JSKN027 Study

MT Newswires Live
·
Mar 17

HK Movers | Biotech Stocks Jump. Wuxi XDC up 7%; Junshi Bio up 6%; Remegen, Genscript Bio, Wuxi Apptec up around 5%; Innocare up over 4%.

Tiger Newspress
·
Mar 17

Alphamab Oncology (09966.HK) Initiates Phase I Trial, First Patient Dosed with PD-L1/VEGFR2 Bispecific ADC JSKN027

Bulletin Express
·
Mar 16

AlphaMab Oncology Announces First Patient Dosed in Phase I Trial for JSKN027

Stock News
·
Mar 16